Furthermore, a recent study found that PIM1 is upregulated in breast cancer cells that are resistant to the PI3K inhibitor BYL719 and that all three PIM kinases are capable of sustaining mTORC1 signaling and cell proliferation in the presence of the inhibitor in these resistant cells55. The gene discussed is PIM1; the disease is breast carcinoma.